| Market Cap | 799M 713M 666M 605M 1.14B 77.37B 1.15B 7.99B 3.13B 39.32B 3B 2.93B 126B | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 964M 861M 803M 730M 1.37B 93.39B 1.39B 9.64B 3.77B 47.45B 3.62B 3.54B 153B | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 799M | |
| -1.61% | +1.72% | +38.30% | +104.56% | 1,060B | |
| -0.76% | -0.84% | +35.21% | +61.78% | 623B | |
| +0.39% | +4.81% | +17.81% | +82.70% | 480B | |
| -0.29% | -0.99% | +64.79% | +36.25% | 352B | |
| -2.03% | +1.03% | +22.25% | +42.16% | 345B | |
| -1.92% | -1.87% | +11.94% | +33.20% | 274B | |
| -2.36% | -3.16% | -6.95% | +8.68% | 249B | |
| -1.37% | +0.04% | +38.29% | +50.05% | 223B | |
| +0.17% | -0.27% | +24.40% | +95.98% | 182B | |
| Average | -1.58% | -0.48% | +27.34% | +57.26% | 420.89B | |
| Weighted average by Cap. | -1.34% | +0.04% | +30.65% | +67.62% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 149M 133M 124M 113M 213M 14.46B 215M 1.49B 584M 7.35B 560M 548M 23.63B | 140M 125M 117M 106M 199M 13.55B 201M 1.4B 547M 6.89B 525M 514M 22.14B |
| Net income | 560K 500K 467K 424K 797K 54.24M 805K 5.6M 2.19M 27.56M 2.1M 2.06M 88.63M | -141M -126M -117M -107M -200M -13.63B -202M -1.41B -551M -6.93B -528M -517M -22.28B |
| Net Debt | 151M 135M 126M 114M 215M 14.65B 217M 1.51B 592M 7.44B 568M 555M 23.93B | 165M 148M 138M 125M 235M 16.01B 238M 1.65B 647M 8.14B 621M 607M 26.17B |
Employees
-
Sector
Pharmaceuticals
